Nicole Bouchard
Overview
Explore the profile of Nicole Bouchard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Labrie V, Lefebvre J, Labbe C, Jao K, Malick M, Simard S, et al.
Front Oncol
. 2024 Dec;
14:1506172.
PMID: 39726712
Introduction: Consolidation durvalumab post chemo-radiotherapy (CRT) has been demonstrated to improve survival in locally advanced non-small-cell lung cancer (NSCLC). Real-world data to assess its use and impact on patients, particularly...
2.
Abi-Zeid I, Bouchard N, Bousquet M, Cerutti J, Dupere S, Fortier J, et al.
Can J Public Health
. 2024 Jul;
115(5):825-833.
PMID: 39042212
Setting: This paper describes an action research project with the Centre universitaire intégré de santé et de services sociaux - Capitale Nationale (CIUSSS-CN) who identified a need to assess vulnerability...
3.
Derosa L, Iebba V, Alves Costa Silva C, Piccinno G, Wu G, Lordello L, et al.
Cell
. 2024 Jun;
187(13):3373-3389.e16.
PMID: 38906102
The gut microbiota influences the clinical responses of cancer patients to immunecheckpoint inhibitors (ICIs). However, there is no consensus definition of detrimental dysbiosis. Based on metagenomics (MG) sequencing of 245...
4.
Tonneau M, Phan K, Manem V, Low-Kam C, Dutil F, Kazandjian S, et al.
Front Oncol
. 2023 Aug;
13:1196414.
PMID: 37546399
Background: Recent developments in artificial intelligence suggest that radiomics may represent a promising non-invasive biomarker to predict response to immune checkpoint inhibitors (ICIs). Nevertheless, validation of radiomics algorithms in independent...
5.
Berard G, Guevremont C, Marcotte N, Schroeder C, Bouchard N, Rajan R
Curr Oncol
. 2023 Mar;
30(3):3251-3262.
PMID: 36975460
Since July 2017, pembrolizumab has been approved as a first-line treatment of metastatic non-small cell lung cancer (NSCLC) in patients with a PD-L1 score ≥ 50% in Quebec. Study objectives...
6.
Derosa L, Routy B, Thomas A, Iebba V, Zalcman G, Friard S, et al.
Nat Med
. 2022 Feb;
28(2):315-324.
PMID: 35115705
Aside from PD-L1 expression, biomarkers of response to immune checkpoint inhibitors (ICIs) in non-small-cell lung cancer (NSCLC) are needed. In a previous retrospective analysis, we documented that fecal Akkermansia muciniphila...
7.
Couetoux du Tertre M, Marques M, McNamara S, Gambaro K, Hoffert C, Tremblay L, et al.
Clin Proteomics
. 2020 Feb;
17:5.
PMID: 32055239
Background: ALK tyrosine kinase inhibition has become a mainstay in the clinical management of ALK fusion positive NSCLC patients. Although ALK mutations can reliably predict the likelihood of response to...
8.
Couetoux du Tertre M, Marques M, Tremblay L, Bouchard N, Diaconescu R, Blais N, et al.
Mol Cancer Ther
. 2019 Jun;
18(9):1628-1636.
PMID: 31243098
Rearrangements in the anaplastic lymphoma kinase () gene are found in approximately 5% of non-small cell lung carcinoma (NSCLC). Here, we present a comprehensive genomic landscape of 11 patients with...
9.
Richman L, Garcia C, Bouchard N, Muskin P, Dzierba A
J Psychiatr Pract
. 2019 Jan;
25(1):63-70.
PMID: 30633735
Background: Alcohol withdrawal is common in hospitalized patients and symptom-triggered guidelines have been shown to reduce treatment duration, length of stay, and need for mechanical ventilation. Objectives: To assess the...
10.
Hoffman R, Mercurio-Zappala M, Bouchard N, Ravikumar P, Goldfrank L
Disaster Med Public Health Prep
. 2011 Nov;
6(1):20-5.
PMID: 22125290
Objectives: Oximes such as pralidoxime (2-PAM) are essential antidotes for life-threatening organophosphate poisoning. Unfortunately, oximes are expensive, have limited use, and have short shelf lives. As such, maintaining large stockpiles...